Pharmacy- Page 29

Roche ranked the most sustainable healthcare company in the DJSI

November 16, 2020

Pharmacy

The FINANCIAL — For the eleventh time, Roche has been recognised as the most sustainable company in the Pharmaceuticals index of the Dow Jones Sustainability Indices (DJSI). This is based on an in-depth analysis of economic, social and environmental performance. The DJSI family of indices serves as a benchmark for investors who integrate sustainability considerations into their portfolios. Roche has

Gilead and Novo Nordisk announced new data from proof-of-concept trial in NASH

The FINANCIAL — Gilead Sciences, Inc. and Novo Nordisk A/S announced results

by The FINANCIAL

November 16, 2020

2 mins read

Metagenomi closes USD 65 million Series A financing led by Leaps by Bayer and Humboldt Fund

The FINANCIAL — Metagenomi, a next generation gene editing company launched by

by The FINANCIAL

November 12, 2020

1 min read

Pharmaceutical industries join to promise fair access to COVID-19 medicines and vaccines

The FINANCIAL — On the occasion of the World Health Assembly, the world’s

by The FINANCIAL

November 12, 2020

1 min read

Pharmacy

Allergan to Acquire ZELTIQ

The FINANCIAL -- Allergan plc and ZELTIQ Aesthetics, Inc. a medical technology company focused on developing and commercializing products utilizing its proprietary controlled-cooling technology platform, on February 13 announced that they have entered into a definitive agreement under which Allergan has

by The FINANCIAL

February 13, 2017

1 min read

Pharmacy

Thomas Cueni Takes Helm of IFPMA as Director General

The FINANCIAL -- Thomas B. Cueni has taken up office as Director General of IFPMA on February 1, representing the interests of the research-based biopharmaceutical industry at a global level.

by The FINANCIAL

February 7, 2017

2 mins read

Pharmacy

Roche reports good results in 2016

The FINANCIAL -- Commenting on the Group’s results, Roche CEO Severin Schwan said:

by The FINANCIAL

February 1, 2017

3 mins read

Pharmacy

Astellas Reports the First Nine Months Financial

The FINANCIAL -- Astellas Pharma Inc. on January 31 announced financial results for three quarters of fiscal year 2016 ending March 31, 2017.

by The FINANCIAL

January 31, 2017

2 mins read

Pharmacy

Exelixis and Takeda Enter into Exclusive Licensing Agreement

The FINANCIAL -- Exelixis, Inc. and Takeda Pharmaceutical Company Limited on January 30 announced an exclusive licensing agreement for the commercialization and further clinical development in Japan of cabozantinib, Exelixis’ lead oncology medicine. With the signing of the agreement, Takeda gains exclusive

by The FINANCIAL

January 31, 2017

2 mins read

Pharmacy

Novartis drug Votubia receives EU approval to treat refractory partial-onset seizures in patients with TSC

The FINANCIAL -- Novartis on January 31 announced that the European Commission has approved Votubia (everolimus) dispersible tablets as an adjunctive treatment for patients aged two years and older whose refractory partial-onset seizures, with or without secondary generalization, are associated with tuberous

by The FINANCIAL

January 31, 2017

2 mins read

Pharmacy

Eli Lilly Q4 Profit Misses, But Revenues Beat

The FINANCIAL -- Eli Lilly and Company on January 31 announced financial results for the fourth quarter and full year of 2016.

by The FINANCIAL

January 31, 2017

16 mins read

Pharmacy

Allergan: FDA Approves SNDA For AVYCAZ To Include Phase III Data

The FINANCIAL -- Allergan plc on January 30 announced the U.S. Food and Drug Administration (FDA) has approved the company's supplemental New Drug Application (sNDA) to update the label for AVYCAZ (ceftazidime and avibactam) with clinical data from two Phase 3 trials

by The FINANCIAL

January 30, 2017

2 mins read

Pharmacy

Novo Nordisk enters collaboration with University

The FINANCIAL -- University of Oxford and Novo Nordisk on January 30 announced a landmark research collaboration focused on type 2 diabetes.

by The FINANCIAL

January 30, 2017

1 min read

Pharmacy

Sanofi Appoints Kathleen Tregoning to Executive Committee and Executive Vice President, External Affairs

The FINANCIAL -- Sanofi on January 30 announced the appointment of Kathleen Tregoning as a new member of the Executive Committee, effective February 27, 2017.

by The FINANCIAL

January 30, 2017

1 min read